Perry Maxwell
0000-0002-4117-1805
Publication & Citation Trends
Publications
0 total
Technical note on the exploration of COVID-19 in autopsy material OA
Cited by 0
Semantic Scholar
Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers OA
Cited by 20
Semantic Scholar
Abstract PD10-08: PD10-08 Immune cell infiltration associated with poor anti-proliferative response to aromatase inhibitors in postmenopausal women with primary ER-positive HER2-negative breast cancer
Cited by 0
Semantic Scholar
Abstract P2-03-08: Deconstructing the molecular characteristics of ER+ HER2+ early breast cancer in the POETIC trial using multiplex immunofluorescence and gene expression profiles
Cited by 0
Semantic Scholar
Abstract PD10-07: PD10-07 Low plasma estradiol, low expression of estrogen responsive genes and TP53 mutations are associated with poor anti-proliferative response to aromatase inhibitors
Cited by 0
Semantic Scholar
ICOSeg: Real-Time ICOS Protein Expression Segmentation from Immunohistochemistry Slides Using a Lightweight Conv-Transformer Network OA
Cited by 5
Semantic Scholar
Abstract A23: True-T – Improved prediction by holistic artificial intelligence-based quantification of T-cell response
Cited by 0
Semantic Scholar
ICOS Protein Expression Segmentation: Can Transformer Networks Give Better Results? OA
Cited by 0
Semantic Scholar
A Means of Assessing Deep Learning-Based Detection of ICOS Protein Expression in Colon Cancer OA
Cited by 27
Semantic Scholar
QuPath: The global impact of an open source digital pathology system OA
Cited by 98
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(18)
Radiomics and Machine Learning in Medical Imaging
(14)
Ovarian cancer diagnosis and treatment
(13)
AI in cancer detection
(11)
PARP inhibition in cancer therapy
(10)
Affiliations
Queen's University Belfast
Belfast Health and Social Care Trust
Belfast Metropolitan College
University of Ulster
University of Bradford